Maravai Lifesciences to acquire DNA and RNA business of Officinae Bio

Maravai LifeSciences (MRVI) “announced that it has signed an agreement to acquire the DNA and RNA business of Officinae Bio. The acquisition is expected to expand Maravai and TriLink BioTechnologies’ ability to assist customers in developing innovative nucleic acid-based therapies.”